168 related articles for article (PubMed ID: 27992120)
21. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling.
Sveshnikova AN; Balatskiy AV; Demianova AS; Shepelyuk TO; Shakhidzhanov SS; Balatskaya MN; Pichugin AV; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Oct; 14(10):2045-2057. PubMed ID: 27513817
[TBL] [Abstract][Full Text] [Related]
22. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study.
Nakazaki M; Oka S; Magota H; Kiyose R; Onodera R; Ukai R; Kataoka-Sasaki Y; Sasaki M; Honmou O
J Stroke Cerebrovasc Dis; 2022 Jul; 31(7):106520. PubMed ID: 35523052
[TBL] [Abstract][Full Text] [Related]
24. Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Franchi F; Rollini F; Cho JR; King R; Phoenix F; Bhatti M; DeGroat C; Tello-Montoliu A; Zenni MM; Guzman LA; Bass TA; Ajjan RA; Angiolillo DJ
Thromb Haemost; 2016 Mar; 115(3):622-31. PubMed ID: 26633836
[TBL] [Abstract][Full Text] [Related]
25. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
27. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
[TBL] [Abstract][Full Text] [Related]
28. Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner.
Vinholt PJ; Nielsen C; Söderström AC; Brandes A; Nybo M
J Thromb Thrombolysis; 2017 Aug; 44(2):216-222. PubMed ID: 28580515
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
[TBL] [Abstract][Full Text] [Related]
30. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
Gurbel PA; Bliden KP; Saucedo JF; Suarez TA; DiChiara J; Antonino MJ; Mahla E; Singla A; Herzog WR; Bassi AK; Hennebry TA; Gesheff TB; Tantry US
J Am Coll Cardiol; 2009 Feb; 53(8):648-57. PubMed ID: 19232896
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
32. Quantification of platelet function - a comparative study of venous and arterial blood using a novel flow cytometry protocol.
Törnudd M; Rodwan Al Ghraoui M; Wahlgren S; Björkman E; Berg S; Kvitting JP; Alfredsson J; Ramström S
Platelets; 2022 Aug; 33(6):926-934. PubMed ID: 35073813
[TBL] [Abstract][Full Text] [Related]
33. Thrombin-induced platelet aggregation -effect of dabigatran using automated platelet aggregometry.
Shimizu M; Natori T; Tsuda K; Yoshida M; Kamada A; Oi K; Ishigaku Y; Oura K; Narumi S; Yamamoto M; Terayama Y
Platelets; 2020; 31(3):360-364. PubMed ID: 31161848
[TBL] [Abstract][Full Text] [Related]
34. PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets.
Harper MT; Poole AW
J Thromb Haemost; 2011 Aug; 9(8):1599-607. PubMed ID: 21649850
[TBL] [Abstract][Full Text] [Related]
35. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic Regulation of
Corbin LJ; White SJ; Taylor AE; Williams CM; Taylor K; van den Bosch MT; Teasdale JE; Jones M; Bond M; Harper MT; Falk L; Groom A; Hazell GGJ; Paternoster L; Munafò MR; Nordestgaard BG; Tybjærg-Hansen A; Bojesen SE; Relton C; Min JL; Davey Smith G; Mumford AD; Poole AW; Timpson NJ
Circ Res; 2022 Feb; 130(3):384-400. PubMed ID: 35012325
[TBL] [Abstract][Full Text] [Related]
38. The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-Mediated Platelet Aggregation.
Trabold K; Makhoul S; Gambaryan S; van Ryn J; Walter U; Jurk K
Thromb Haemost; 2019 Jun; 119(6):916-929. PubMed ID: 31005062
[TBL] [Abstract][Full Text] [Related]
39. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.
Testa S; Legnani C; Tripodi A; Paoletti O; Pengo V; Abbate R; Bassi L; Carraro P; Cini M; Paniccia R; Poli D; Palareti G
J Thromb Haemost; 2016 Nov; 14(11):2194-2201. PubMed ID: 27566988
[TBL] [Abstract][Full Text] [Related]
40. Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin.
Boncler MA; Koziolkiewicz M; Watala C
Thromb Res; 2001 Nov; 104(3):215-22. PubMed ID: 11672764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
